8U6-42864-65693 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-24
Dose 1 — Pfizer-BioNTech
2021-08-25
Registered in v-safe
2021-08-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-02
Survey response — day 7, dose 1
MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Good

Free text: Runny/stuffy nose

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-15
Dose 2 — Pfizer-BioNTech
2021-09-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Chills, Headache, Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-09-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-10-27
Survey response — day 42, dose 2
MedDRA: Nasopharyngitis, Pregnancy — Feeling: Good · Be unable to do your normal daily activities

Free text: Just a cold and pregnancy symptoms

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-24	Pfizer-BioNTech	No
2	2021-09-15	Pfizer-BioNTech	No

Free text

Release 9 — day 7, dose 1

2021-09-02

Systemic reaction (other): Runny/stuffy nose

Release 10 — day 42, dose 2

2021-10-27

Symptoms: Just a cold and pregnancy symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓
SD	Pregnancy	·	·	✓
SRO	Nasal congestion	✓	·	✓
SRO	Rhinorrhoea	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release